Results 281 to 290 of about 480,865 (305)

An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting

Annals of Oncology, 2012
Tetsuya Mitsudomi, G Ishii
exaly  

EGFR

2017
openaire   +1 more source

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling

Cancer Cell, 2019
Zhi-Ming Shao, Toni Celià-Terrassa
exaly  

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio De Vito   +2 more
exaly  

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

Journal of Thoracic Oncology, 2015
Shaodong Hong, Shiyang Kang, Yanna Tang
exaly  

Treating EGFR-mutant nonsmall cell lung cancer is no longer a one-size-fits-all approach

Ca-A Cancer Journal for Clinicians
Jyoti Malhotra, Lauren Antrim
exaly  

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

Journal of Hematology and Oncology, 2015
Minglei Zhuo, Xiaomei Su, Meina Wu
exaly  

Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification

Ca-A Cancer Journal for Clinicians
Hina Khan, Gilberto de Lima Lopes, Hina Khan   +2 more
exaly  

Targeting the EGFR signaling pathway in cancer therapy

Expert Opinion on Therapeutic Targets, 2012
Moorthy Palanimuthu Ponnusamy, Surinder K Batra, Maneesh Jain   +2 more
exaly  

Response to EGFR blockade

2021
VELCULESCU VICTOR, PAPP ENIKO, ADLEFF VILMOS, BERTOTTI ANDREA, TRUSOLINO LIVIO   +4 more
openaire   +4 more sources